Impact of a Histamine H2 Receptor Antagonist (H2RA) on the Pharmacokinetics (PK) of Telaglenastat in Healthy Subjects

NCT04540965 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interaction

Interventions

DRUG: Telaglenastat
DRUG: Famotidine
DRUG: Placebo for famotidine

Sponsor

Calithera Biosciences, Inc

Collaborators

[object Object]